• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER GMBH CLS SPOTORNO, STEM, 135, UNCEMENTED, 10.0, TAPER 12/14; CLS SPOTORNO STEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER GMBH CLS SPOTORNO, STEM, 135, UNCEMENTED, 10.0, TAPER 12/14; CLS SPOTORNO STEM Back to Search Results
Model Number N/A
Device Problems Use of Device Problem (1670); Device-Device Incompatibility (2919); Appropriate Term/Code Not Available (3191)
Patient Problems Injury (2348); No Code Available (3191)
Event Date 04/19/2016
Event Type  Injury  
Manufacturer Narrative
The manufacturer did not receive devices, x-rays, or other source documents for review as the patient was not revised.Where lot numbers were received for the devices, the device history records were reviewed and found to be conforming.Due to fact that this is a legal claim, our legal department has been provided with the available facts from the customer.Zimmer (b)(4) legal department is well trained and passes all information concerning the case to our complaint handling department.As soon as supplemental information becomes available an updated report will be submitted.According to the provided information, the current situation reflects an off-label use, i.E.Contraindicated use as described in zimmer's instruction for use.Zimmer's reference number of this file is (b)(4).This is a bilateral patient.Right hip case is reported under (b)(4).
 
Event Description
The patient is pursuing a product liability claim.The patient was implanted a cls spotorno, stem, 135, uncemented, 10.0, taper 12/14 on (b)(6) 2008.A revision surgery was planned on an unknown date due to unknown reasons.It was also reported that the surgeon combined the stem with competitor's products.According to the provided information, the current situation reflects an off-label use.Since the exact date of the event was not reported, it will be entered as the date of awareness.
 
Manufacturer Narrative
Investigation results were made available.Dhr review: the device manufacturing quality records indicate that the released components met all requirements to perform as intended.Trend analysis: no trend was identified.Review of event description: it was reported that the patient was implanted a cementless hip tep on left hip on (b)(6) 2008.Competitor's product were combined with the zimmer biomet stem.The patient suffers from pain.Review of received data: only an attorney letter and the product stickers were received.Devices analysis: no product was returned to zimmer biomet for in-depth analysis.Review of product documentation: the compatibility check was performed from www.Productcompatibility.Zimmer.Com and showed that the product combination was not approved by zimmer biomet.The instruction for use for cls stems was reviewed; it states that ¿only authorized combinations must be used.To determine whether these devices have been authorized for use in a proposed combination, please contact your zimmer sales representative or visit the zimmer website: www.Productcompatibility.Zimmer.Com.¿ root cause determination using dfmea: aseptic loosening due to surgeon does not comply to surgical technique (early stability) => possible: the cls stem was combined with competitor's products.Failure of connection between stem and ball head due to improper connection of ball head during surgery => possible: the cls stem was combined with competitor's products.Aseptic loosening, migration of stem short and long term due to wrong handling of the stem, splitting of femur due to surgeon does not comply to surgical technique => possible: the cls stem was combined with competitor's products.Migration of stem short and long term, splitting of femur due to surgeon chooses wrong indications => possible: the cls stem was combined with competitor's products.Migration/subsidence of stem short and long term, splitting of femur due to wrong size implanted (wrong size chosen) => possible: the x-rays and surgical reports were not available, therefore cannot be excluded.Conclusion summary: it was reported that the cls stem was combined with competitor's products.Therefore, we consider the root cause for this case as off-label use.The need for corrective measures is not indicated and zimmer (b)(4) considers this case as closed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLS SPOTORNO, STEM, 135, UNCEMENTED, 10.0, TAPER 12/14
Type of Device
CLS SPOTORNO STEM
Manufacturer (Section D)
ZIMMER GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ  8404
Manufacturer (Section G)
ZIMMER GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ   8404
Manufacturer Contact
kevin escapule
1800 west center street
warsaw, IN 46580
8006136131
MDR Report Key5652409
MDR Text Key45111455
Report Number0009613350-2016-00679
Device Sequence Number1
Product Code LZO
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Attorney
Type of Report Initial,Followup
Report Date 04/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/13/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/31/2012
Device Model NumberN/A
Device Catalogue Number29.00.39-100
Device Lot Number2413768
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/25/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/05/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age60 YR
-
-